Owkin
Laurent Higueret is the current director at Owkin. Prior to this, they worked on an entrepreneurial project in healthcare services from January 2012 to December 2013. Before that, they worked as an M&A associate for BNP Paribas Corporate & Investment Banking from January 2006 to December 2011.
Laurent has six years of experience in investment banking, advising and executing large M&A and financing transactions across a wide range of healthcare sub-sectors. Laurent has experience in a variety of industries, including healthcare, banking, and investment.
Laurent Higueret has a postgraduate master's degree in financial engineering from emlyon business school, a master of science in business administration and management from KEDGE Business School, and a doctor of pharmacy from Université de Bordeaux.
This person is not in the org chart
This person is not in any offices
Owkin
6 followers
Owkin believes that medical research should be collaborative, inclusive, and privacy-preserving. Today, Owkin is pioneering AI in healthcare. It leverages its collaborative federated learning software and expert AI capabilities to bring solutions to optimize drug development and improve patient care in oncology. Owkin’s work has been published in Nature Medicine and other top-tier journals. Owkin has raised over $70M from leading VC funds and is now working with the most prominent cancer centers and pharmaceutical companies in Europe and the US. Additionally, Owkin leads several federated learning consortia, including; MELLODDY, to facilitate 'co-opetive' drug discovery between pharma companies, and Healthchain, to allow collaborative research across multiple hospitals. Owkin was co-founded in 2016 by Thomas Clozel, MD, a clinical research doctor and former assistant professor in clinical hematology, and by Gilles Wainrib, Ph.D., an academic pioneer in the field of Artificial Intelligence in biology.